131 related articles for article (PubMed ID: 8758266)
1. Increasing the dose intensity of chemotherapy by means of granulocyte-colony stimulating factor (G-CSF) support in the treatment of small cell lung cancer (SCLC).
Girling DJ; Thatcher N; Clark PI; Stephens RJ
Eur J Cancer; 1996 Jun; 32A(7):1263. PubMed ID: 8758266
[No Abstract] [Full Text] [Related]
2. Received dose-intensity: a randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer.
Miles DW; Fogarty O; Ash CM; Rudd RM; Trask CW; Spiro SG; Gregory WM; Ledermann JA; Souhami RL; Harper PG
J Clin Oncol; 1994 Jan; 12(1):77-82. PubMed ID: 7505809
[TBL] [Abstract][Full Text] [Related]
3. Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer.
Woll PJ; Hodgetts J; Lomax L; Bildet F; Cour-Chabernaud V; Thatcher N
J Clin Oncol; 1995 Mar; 13(3):652-9. PubMed ID: 7533825
[TBL] [Abstract][Full Text] [Related]
4. Is more better? Chemotherapy for patients with extensive-stage small-cell lung cancer.
Johnson BE
J Natl Cancer Inst; 2001 Feb; 93(4):254-5. PubMed ID: 11181764
[No Abstract] [Full Text] [Related]
5. Incidence of neutropenic fever in patients treated with standard-dose combination chemotherapy for small-cell lung cancer and the cost impact of treatment with granulocyte colony-stimulating factor.
Nichols CR; Fox EP; Roth BJ; Williams SD; Loehrer PJ; Einhorn LH
J Clin Oncol; 1994 Jun; 12(6):1245-50. PubMed ID: 7515413
[TBL] [Abstract][Full Text] [Related]
6. Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer Working Party.
Thatcher N; Girling DJ; Hopwood P; Sambrook RJ; Qian W; Stephens RJ
J Clin Oncol; 2000 Jan; 18(2):395-404. PubMed ID: 10637255
[TBL] [Abstract][Full Text] [Related]
7. A combination chemotherapy of carboplatin and irinotecan with granulocyte colony-stimulating factor (G-CSF) support in elderly patients with small cell lung cancer.
Okamoto H; Naoki K; Narita Y; Hida N; Kunikane H; Watanabe K
Lung Cancer; 2006 Aug; 53(2):197-203. PubMed ID: 16781005
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony-stimulating factor with or without antimicrobial prophylaxis in patients with small-cell lung cancer.
Ardizzoni A; Pennucci MC; Danova M; Viscoli C; Mariani GL; Giorgi G; Venturini M; Mereu C; Scolaro T; Rosso R
Br J Cancer; 1996 Oct; 74(7):1141-7. PubMed ID: 8855989
[TBL] [Abstract][Full Text] [Related]
9. Weekly dose-dense cisplatin-epirubicin-paclitaxel administration with granulocyte colony-stimulating factor support does not substantially improve prognosis in extensive disease small-cell lung cancer. A SICOG phase II study.
Frasci G; Comella P; Carreca I; DeCataldis G; Muci D; Brunetti C; Russo A; Palmeri S; D'Aniello R; Giordano R; D'Aiuto M; Comella G;
Oncology; 2005; 68(2-3):223-9. PubMed ID: 16015038
[TBL] [Abstract][Full Text] [Related]
10. Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
Masuda N; Fukuoka M; Kudoh S; Matsui K; Kusunoki Y; Takada M; Nakagawa K; Hirashima T; Tsukada H; Yana T
J Clin Oncol; 1994 Sep; 12(9):1833-41. PubMed ID: 7521905
[TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy in small cell lung cancer.
Pasini F; Pelosi G; De Manzoni G; Rosti G
Tumori; 2002; 88(3):179-86. PubMed ID: 12195754
[TBL] [Abstract][Full Text] [Related]
12. CODE chemotherapy with or without recombinant human granulocyte colony-stimulating factor in extensive-stage small cell lung cancer.
Masuda N; Fukuoka M; Furuse K
Oncology; 1992; 49 Suppl 1():19-24. PubMed ID: 1380148
[TBL] [Abstract][Full Text] [Related]
13. High-dose chemo-radiotherapy cycles for LD small cell lung cancer patients using G-CSF and blood stem cells.
Humblet Y; Bosquée L; Weynants P; Symann M
Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S36-9. PubMed ID: 8899169
[No Abstract] [Full Text] [Related]
14. [Dose intensity chemotherapy in lung cancer].
Takada M; Fukuoka M; Negoro S; Masuda N; Kudo S
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2005-12. PubMed ID: 1699498
[TBL] [Abstract][Full Text] [Related]
15. Dose intensity in small cell lung cancer.
Thatcher N; Lee SM; Woll PJ; Middleton M; Anderson H; Burt P; Stout R
Semin Oncol; 1998 Apr; 25(2 Suppl 4):12-8; discussion 45-8. PubMed ID: 9578057
[TBL] [Abstract][Full Text] [Related]
16. Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma.
Tjan-Heijnen VC; Biesma B; Festen J; Splinter TA; Cox A; Wagener DJ; Postmus PE
J Clin Oncol; 1998 Aug; 16(8):2708-14. PubMed ID: 9704721
[TBL] [Abstract][Full Text] [Related]
17. A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer.
Eguchi K; Etou H; Miyachi S; Morinari H; Nakada K; Noda K; Ohkuni Y; Watanabe K; Yamada Y; Ohe Y
Eur J Cancer; 1994; 30A(2):188-94. PubMed ID: 7512356
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer.
Gridelli C; Perrone F; D'Aprile M; Rossi A; Palmeri S; Curcio C; Veltri E; Ianniello G; Lorusso V; Palmieri G
Eur J Cancer; 1995 Dec; 31A(13-14):2424-6. PubMed ID: 8652288
[No Abstract] [Full Text] [Related]
19. The feasibility of using glycosylated recombinant human granulocyte colony-stimulating factor (G-CSF) to increase the planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer. Medical Research Council Lung Cancer Working Party.
Thatcher N; Anderson H; Bleehen NM; Girling DJ; Lallemand G; Machin D; Stephens RJ
Eur J Cancer; 1995; 31A(2):152-6. PubMed ID: 7536433
[TBL] [Abstract][Full Text] [Related]
20. Dose-intensive chemotherapy in extensive-stage small cell lung cancer.
Fukuoka M; Masuda N; Takada M; Kodama N; Kawahara M; Furuse K
Semin Oncol; 1994 Feb; 21(1 Suppl 1):43-7. PubMed ID: 7512276
[No Abstract] [Full Text] [Related]
[Next] [New Search]
